0001855763-22-000019.txt : 20221018
0001855763-22-000019.hdr.sgml : 20221018
20221018182031
ACCESSION NUMBER: 0001855763-22-000019
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221012
FILED AS OF DATE: 20221018
DATE AS OF CHANGE: 20221018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BUNKA CHRISTOPHER
CENTRAL INDEX KEY: 0001103780
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39874
FILM NUMBER: 221316860
MAIL ADDRESS:
STREET 1: 1924 BIRKDALE AVE
CITY: KELOWNA
STATE: A1
ZIP: V1P1R7
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexaria Bioscience Corp.
CENTRAL INDEX KEY: 0001348362
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202000871
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
BUSINESS PHONE: 250-765-6424
MAIL ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
FORMER COMPANY:
FORMER CONFORMED NAME: LEXARIA CORP.
DATE OF NAME CHANGE: 20080229
FORMER COMPANY:
FORMER CONFORMED NAME: Lexaria Corp.
DATE OF NAME CHANGE: 20051229
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2022-10-12
2022-10-13
0
0001348362
Lexaria Bioscience Corp.
LEXX
0001103780
BUNKA CHRISTOPHER
1924 BIRKDALE AVE
KELOWNA
A1
V1P1R7
BRITISH COLUMBIA, CANADA
1
1
0
0
Chief Executive Officer
common shares
273543
D
common shares
215912
I
Private Holding Company
common shares
2022-10-12
4
P
0
21900
1.988
A
237812
I
Private Holding Company
common shares
2022-10-13
4
P
0
16600
2.1
A
254412
I
Private Holding Company
This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022.
/Chris Bunka/
2022-10-18